| Gemma Rose Cohen, RN | |
|
721 Baker St, San Francisco, CA 94115-4304 | |
| (641) 919-7259 | |
| Not Available |
| Full Name | Gemma Rose Cohen |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 721 Baker St, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003402942 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 95111520 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gemma Rose Cohen, RN 721 Baker St, San Francisco, CA 94115-4304 Ph: (641) 919-7259 | Gemma Rose Cohen, RN 721 Baker St, San Francisco, CA 94115-4304 Ph: (641) 919-7259 |
News Archive
In this post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, the second in a multi-week series, Joy Lawn, director of Evidence and Policy for the Saving Newborn Lives program of Save the Children, and Kate Kerber, the Africa regional specialist with Saving Newborn Lives at Save the Children U.S., "explore the pressing need - and what our partners are doing to address the need - to save the lives of women and newborns in India,".
To continue meeting the ever-advancing technological needs of our patients, Memorial Sloan Kettering Cancer Center has debuted MyMSK, a new mobile application. The app, compatible with iPad, iPhone, and all iOS devices, allows MSK patients to quickly and easily access their lab and radiology results, view their upcoming appointments, record their medications and symptoms in online diaries, communicate with their healthcare team, and more.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi therapeutic program targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of porphyria including acute intermittent porphyria.
Researchers have used a genetic engineering strategy to dramatically reduce levels of tau-a key protein that accumulates and becomes tangled in the brain during the development of Alzheimer's disease-in an animal model of the condition.
More than one million people in the United States are afflicted with Parkinson's disease, a progressive disorder of the brain that affects movement and coordination. The cause is typically unknown, and presently there is no cure for the disease.
› Verified 1 days ago
Rocio C Agraz-lara, RN, PHN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1001 Potrero Ave, Zsfg Building 90 4th Floor, San Francisco, CA 94110 Phone: 415-206-8524 Fax: 415-206-6545 | |
Ms. Cecile A O'connor, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 52 Dore St, San Francisco, CA 94103 Phone: 415-861-0828 Fax: 415-861-0140 | |
Mr. Gregory Sumner Payne Brynelson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 555 Mission Rock St Unit 103, San Francisco, CA 94158 Phone: 415-513-2902 | |
Elisabeth Leslie Goldstein, RN, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1171 Mission St, San Francisco, CA 94103 Phone: 415-734-4231 Fax: 415-734-4218 | |
Michalle Ramirez-mclaughlin, RN, FNP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1545 Divisadero St, San Francisco, CA 94143 Phone: 415-353-7900 | |
Araceli Sanchez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-476-1000 |